Cell Therapy BioCollagen Platform Life Science About RMS News Room IRS Support
Cell Therapy
ADIFORM
DERMAN
BABYCELL
BioCollagen
THERACOL®
RMS BioCollagen™
Liposome™
THERAFILL®
THERAFORM™
NOVOSTRATA
Platform
Platform
Operating Software
Apparatus & Instrument
Life Science
GLP Service
CRO Service
Labware
Regent
About RMS
Overview
Company Background
History
Market
Certificate
Location
Bio-Network
News Room
News Releases
Exhibition Schedule
IRS
About IRS
News & Journals
Member Services
Global Network
Support
Contact
Download
News Releases
TheraForm, received 510(k) clearance from the FDA
Sewon Cellontech has announced that TheraForm™ Standard and Sheet types have been cleared for marketing in the United States of America through the 510(k) Premarket Notification. Theraform is intended for the management of wound d...
Date : Sep 01, 2009
RMS Workshop for Technology transfer
Sewon Cellontech implemented a workshop of RMS technology transfer with key doctors from Poland and India including technical training on cell therapeutics. The technical training was performed by RMS Laboratory specialists of Sewon Cellontech for a period of one week from 2...
Date : May 07, 2007
LOI of RMS supply agreed with a Malay company
Sewon Cellontech announced that LOI(Letter of Intent) was agreed between Sewon Cellonteh and Spine Innovations (M) Sdn. Bhd., Malaysia to supply RMS H-class platform. As per this LOI, it will be entered into RMS supply agreement in June this year, indicating that RM Kit incl...
Date : May 07, 2007
UCL signs business agreement with Sewon Cellontech
UCL Business PLC and the Royal National Orthopaedic Hospital NHS Trust (RNOH) have signed an agreement with Sewon Cellontech (SC) of South Korea to collaborate on new laboratories that will develop clinical cell therapeutic treatments for cartilage repair and bone fracture h...
Date : May 07, 2007
Acquired Patent for the method of sourcing and manufacturing atelocollagen
Sewon Cellontech has acquired a patent for method of isolating collagen from animal tissue, formulating its collagen solution and manufacturing bio-matrix using its atelocollagen. With this patent, the company is capable to isolate collagen effectively from bone, cartilage,...
Date : May 07, 2007
ACI for Cartilge RMP (Chondron™) was successfully operated in India
Personalized cell therapy product Chondron™ (Cartilage RM therapy product) which was exported to India was successfully operated in New Delhi, India. The ACI case was introduced by Sewon Cellontech and operated by Dr. Seok-Jung Kim from Catholic Univ. of Korea for the first ...
Date : May 07, 2007
      1 2 3 4 5 [6] 7